France Archives

News and Trends 22 May 2015

Fluorescent antibodies to guide Cancer surgery

French oncologist SurgiMab has started a first-in-human phase I study for its molecule SGM-101 launched at the Montpellier Cancer Institute. SurgiMab is developing antibody-fluorochrome conjugates to be used as in vivo diagnostic agents in oncology. SGM-101 is a fluorescent conjugate that consists on a tumor-specific monoclonal antibody and a near-infrared emitting fluorochrome. Thanks to this conjugate, oncology surgeons will […]

May 22, 2015 - 1 minutemin - By Lourdes Riquelme

IBN One Cristal union Global bioenergies

News and Trends 21 May 2015

Will France become a leader in isobutene production?

Cristal Union and Global Bioenergies have formed a joint venture, entitles IBN-One, to build and operate France’s first bio-sourced isobutene production plant. IBN-One is a limited liability corporation jointly owned by the two companies. The two French companies already collaborated to develop the scaling up of the isobutene production process. Thanks to the partnership, the […]

May 21, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 20 May 2015

Ipsen acquired OctreoPharm to strengthen its Oncology presence

Ipsen is determined to increase its presence in the oncology field, by acquiring OctreoPharm Sciences. The German life sciences company is focused on the development of radioactive labeled compounds for molecular imaging diagnostics and therapeutic applications. OctreoPharm’s shareholders are eligible to receive up to a total of approximately €50M for the purchase of 100% of […]

May 20, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 18 May 2015

ZuvaSyntha, a new player in the Industrial Biotech field

UK-based BioSyntha Technology and American ZuvaChem have merged and become ZuvaSyntha, an aspiring new player in the industrial biotechnology field. The new company will focus its resources to commercialize the microbial production of industrial chemicals from inexpensive renewable feedstocks, such as syngas and methanol. ZuvaSyntha, will be based in the UK and will be led […]

May 18, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 17 May 2015

The Miracle Berry which Hacks your Taste Buds to Replace Sugar

Can you name a fruit capable of disturbing your taste buds? For up to two hours, the red miracle berry can transform sour foods like lemon or vinegar, in an amazing sweet taste. It’s a very interesting berry because of its non-caloric property for anti-obesity and anti-diabetes use. This miracle berry that grows in West Africa contains Miraculin, […]

May 17, 2015 - 3 minutesmins - By Julie Lellouche

News and Trends 14 May 2015

Selecta continues its tour around France with another collaboration

Selecta Biosciences and Généthon are collaborating to enable repeat dosing for gene therapies. The companies are combining Généthon’s expertise in the development of gene therapy vectors and Selecta’s Synthetic Vaccine Particle platform to prevent undesired immune responses. Selecta seems quite fond of collaborating with French companies. After allying with Sanofi, the US-based company has announced […]

May 14, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 13 May 2015

Sanofi and Selecta will develop a “Negative Vaccine” for Celiac Disease

Sanofi and Selecta Biosciences are going to extend their three-year-old partnership to develop an immunotherapy for the treatment of celiac disease. Selecta may receive €264M from the biggest French Pharma company, in terms of research support and sales milestones. The two companies are now collaborating on three programs for immune tolerance. In celiac disease patients, […]

May 13, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 11 May 2015

Ecrins Therapeutics’ first fundraising entirely crowdfunded by WiSEED

Ecrins Therapeutics, the company we interviewed last week, has successfully finished its first crowdfunding fundraiser, reaching €535k on WiSEED’s platform. The capital will allow the company to launch the large-scale chemical synthesis and regulatory toxicology studies, essential groundwork for the start of clinical Phase I/IIa. A second fundraise is already programmed in 2016 to finance […]

May 11, 2015 - 4 minutesmins - By Marie Godar

News and Trends 6 May 2015

Global Bioenergies produced its First batch of Isobutene in a record time

Global Bioenergies delivered the first batch of isobutene from renewable resources to its partner Arkema six months ahead of the projected schedule. Thanks to the cooperation of ARD’s, an affiliate of the French sugar producer Cristal Union, and Global Bioenergies’ teams, the scaling up of the process in the industrial pilot has been achieved in […]

May 6, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 6 May 2015

Hello Tomorrow Challenge, a preview of the startup competition

Hello Tomorrow’s main goal is to create bridges between scientists, investors and entrepreneurs in all major technological fields. On 9th of April 2015, the team of Hello Tomorrow invited us to attend to their press conference given at the Ministry of Foreign Affairs in Paris. In April 2014, after three long years of preparation, the “First day […]

May 6, 2015 - 3 minutesmins - By Joachim Eeckhout

News and Trends 5 May 2015

Natural Killer therapies for Cancer: a Fast-Evolving field

Natural killers are an emerging approach to fight inflammatory diseases and cancer. These immune actors, that specifically regulate the activity of the immune system, are attracting the attention of several small startups and more than a few big Pharmas. The immune system includes a set of body defenses, that fight foreign forms. But external bodies aren’t […]

May 5, 2015 - 3 minutesmins - By Lourdes Riquelme

News and Trends 3 May 2015

After its IPO, Poxel maintains its promise to develop a new Type 2 diabetes drug

Poxel continues to interest the market after its successful IPO in February 2015, where it has raised approximately €27M with an incredible jump of +100% on its third day as a public company. Imeglimin, its lead candidate, is a Type 2 diabetes treatment (licensed by Merck Serono) on the launch of Phase III. This innovative compound is […]

May 3, 2015 - 3 minutesmins - By Joachim Eeckhout

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

France

Fluorescent antibodies to guide Cancer surgery

Will France become a leader in isobutene production?

Ipsen acquired OctreoPharm to strengthen its Oncology presence

ZuvaSyntha, a new player in the Industrial Biotech field

The Miracle Berry which Hacks your Taste Buds to Replace Sugar

Selecta continues its tour around France with another collaboration

Sanofi and Selecta will develop a “Negative Vaccine” for Celiac Disease

Ecrins Therapeutics’ first fundraising entirely crowdfunded by WiSEED

Global Bioenergies produced its First batch of Isobutene in a record time

Hello Tomorrow Challenge, a preview of the startup competition

Natural Killer therapies for Cancer: a Fast-Evolving field

After its IPO, Poxel maintains its promise to develop a new Type 2 diabetes drug

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!